Overall value growth in dermatologicals is not set to be impacted by the outbreak of COVID-19 in 2020, as growth is predicted to align to that of 2019. However, some areas will see a change in demand due to COVID-19 restrictions.
Hair loss treatments is predicted to record a decline in growth in 2020; however, this is not the result of the COVID-19 pandemic, rather a continued decrease in sales. A decline in this area is due to two factors; firstly, many consumers question the reliability of these products, and therefore, few Danish men believe that these products work.
Growth is set to increase in 2021 compared to 2020, boosted by medicated shampoos and antiparasitics/lice (head and body) treatment, with antiparasitics/lice (head and body) treatment seeing an increase as children attend school once again, socialising with friends and increasing the prevalence of lice. In addition, sales of topical allergy remedies/antihistamines, which saw a decline in 2020 compared to 2019, will rise back up, boosting overall sales in the landscape.
The ageing population of the country is also expected to continue driving growth across the forecast period, with older consumers being an ongoing contributor to growth in dermatologicals. This will continue to be the case, as the population of over 65-years-olds is increasing in Denmark, boosting sales of hair loss treatments and other skin treatments.
Chemists are expected to continue being the leading distribution channel for dermatologicals across the forecast period; however, as OTC products become increasingly available in retailers as well as through e-commerce, it is expected that their share will continue to decline over the forecast period. In 2020 e-commerce will record strong growth due to the outbreak of COVID-19, as consumers sought to minimise their exposure risk by shopping online.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Denmark with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Denmark, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page